Implementation of an antibacterial envelope during de novo implantation of ICD system in secondary SCD prevention in a patient on immunosuppressive treatment

Implantation of cardioverter-defibrillator system is necessary and it needs to be performed as soon as possible in patients with secondary sudden cardiac death prevention including resynchronization therapy indications. Patients on active immunosuppressive treatment are at the highest risk of infective complications of every kind of surgical intervention. In the case of cardiac implantable devices implementation of an antibacterial envelope could be a relevant factor in infective risk prevention.

